Ads by Google
Beaumont is the first hospital in metro Detroit to treat patients in a clinical study evaluating the MitraClip system to repair the mitral valve without open-heart surgery. The MitraClip device is used for patients with moderately severe to severe mitral regurgitation, the most common type of heart valve problem. With the clip, Beaumont interventional cardiologists and echocardiologists are able to repair defective mitral valves with a nonsurgical procedure in the cardiac catheterization lab in about two hours.
A new cardiac treatment facility that couples the benefits of interventional cardiology with cardiothoracic surgery for critically ill newborns, children and adults has opened at Rush University Medical Center.
Major complications following coronary artery bypass graft surgery, even among patients least at risk of experiencing complications, remain common and add significantly to healthcare costs, while diminishing the benefits of surgery
Coinciding with the BIO International Convention held introduces the "Mouse Stent Model" for rapid screening of new coronary stent therapeutics.
Researchers report the first concrete evidence that treatment with activated vitamin D can protect against heart failure.
Two long-term, large-scale and independent studies evaluating cardiovascular outcomes in people with type 2 diabetes enrolled more than 9,300 patients taking AVANDIA and provide more than 20,000 patient years of additional experience with AVANDIA.
Heart transplants save the lives of more than 2,100 Americans every year. But many more patients are still waiting for a new heart to become available, and hundreds will die without ever getting a second chance at life.
Meanwhile, tens of thousands more people aren't sick enough to need a transplant, but struggle every day with severe heart failure that limits all aspects of their lives.
Could technology be the solution - whether temporary, or permanent - for many of these people? Could heart transplants ever become a thing of the past?